Full-Time

Cloud Infrastructure Engineer

RefinedScience

RefinedScience

Data-driven precision medicine for trials

Compensation Overview

$110k - $130k/yr

Remote in USA

Remote

Bachelor's

Category
DevOps & Infrastructure (1)
Required Skills
Microsoft Azure
Python
GitHub Actions
Computer Networking
Docker
AWS
Terraform
Observability
Linux/Unix
Google Cloud Platform

Get referred to RefinedScience

See people who can refer or advise you

Requirements
  • Bachelor’s degree in Computer Science, Engineering, or equivalent practical experience
  • Experience in cloud engineering, infrastructure engineering, or a closely related role
  • Strong proficiency with Google Cloud Platform; equivalent experience with Amazon Web Services or Microsoft Azure will be considered
  • Linux administration and comfort working in Linux-based environments via command line
  • Hands-on experience with infrastructure as code with Terraform and or Pulumi
  • Demonstrated experience building and maintaining CI/CD pipelines (GitHub Actions, Google Cloud Build, or similar)
  • Solid understanding of cloud networking: VPC design, load balancers, DNS, NAT, and firewall rule management
  • Hands-on experience with metrics collection and building operational dashboards
  • Experience scripting or automating infrastructure tasks in Python or a similar language
  • Strong written and verbal communication skills with an ability to produce clear technical documentation
  • Ability to work both independently and collaboratively within a cross-functional team
Responsibilities
  • Design and implement cloud infrastructure on Google Cloud Platform using infrastructure as code
  • Manage cloud networking components including VPCs, load balancers, DNS, Cloud Router, NAT, and firewall rules
  • Manage and optimize cloud compute resources including Google Compute Engine instances, Cloud Run, and related services
  • Build and maintain CI/CD pipelines using tools such as GitHub Actions or Google Cloud Build to support reliable, repeatable deployments
  • Design and maintain observability infrastructure including metrics collection, log aggregation, and dashboards to surface actionable insights for engineering and research teams
  • Implement and maintain security and compliance controls appropriate to a regulated healthcare research environment
  • Manage cloud services including backup and disaster recovery
  • Support deployment and maintenance of internal applications and their underlying infrastructure
  • Champion containerization best practices and support containerized workload deployments
  • Collaborate with cross-functional teams to ensure seamless integration with existing systems and workflows
  • Troubleshoot and resolve cloud infrastructure and deployment issues
  • Create and maintain clear technical documentation, runbooks, and architecture diagrams
  • Stay current with cloud technology trends and evaluate new tools and approaches relevant to the organization
Desired Qualifications
  • Experience in a healthcare or life sciences environment; working knowledge of HIPAA compliance requirements
  • Experience with GCP-native observability tooling (Cloud Monitoring, Cloud Logging) in addition to Prometheus/Grafana
  • Experience with cloud Identity and Access Management best practices and security controls (VPC Service Controls, service accounts, least-privilege patterns)
  • Experience with front-end application hosting infrastructure (load balancers, SSL/TLS termination, CDN)
  • Google Cloud Professional certification (Cloud Architect, DevOps Engineer, or similar)
  • Familiarity with containerization technologies, primarily Docker; Kubernetes exposure is a plus but not required

RefinedScience builds a data platform that combines clinical and biological data to support precision drug development and clinical trial optimization using AI and machine learning. It curates high-fidelity data and runs computational analyses to identify which patients are most likely to respond and how to design trials, delivering data-driven insights as a service to pharmaceutical companies and healthcare institutions. Unlike providers that only offer datasets, RefinedScience integrates rich data with advanced analytics to give actionable, patient-focused guidance. Its goal is to improve patient outcomes and shorten drug development timelines by increasing trial success and speeding up discovery to approval.

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

Aurora, Colorado

Founded

2019

Get referred to RefinedScience

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • October 2025 Verily partnership expands distribution into a major healthcare AI ecosystem.
  • The AML dataset showed 95%+ accuracy and 30x faster extraction, strengthening commercialization.
  • Permanent Bioscience 3 headquarters in 2024 signals long-term commitment and hiring capacity.

What critics are saying

  • RefinedScience’s 18-person team cannot support enterprise sales, curation, and platform delivery.
  • Its moat depends on UCHealth and CU Anschutz access; partner drift kills supply.
  • If Verily or academia internalizes this workflow by 2027, RefinedScience becomes redundant.

What makes RefinedScience unique

  • RefinedScience’s October 2025 Verily collaboration validates its AI-ready clinical data pipeline.
  • Its UCHealth and CU Anschutz joint venture gives proprietary access to multiomic patient data.
  • The Verily Exchange now hosts its AML dataset, proving marketable data-product traction.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Paid Vacation

Paid Holidays

Paid Sick Leave

401(k) Retirement Plan

Company News

Business Wire
Nov 22nd, 2024
OncoVerity Secures Extended Series A to Advance Cusatuzumab in Newly Diagnosed AML

Alongside financing, first patients dosed in OV-AML-1231, a Phase 2 randomized controlled trial of cusatuzumab in newly diagnosed AML